Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-04 4:17 pm Purchase | 2021-12-31 | 13G | VIVEVE MED INC PAR $ VIVE | Hudson Bay Capital Management LP | 258,064 2.380% | 17,075 (+7.09%) | Filing History |
| 2022-02-04 4:15 pm Unchanged | 2021-12-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Hudson Bay Capital Management LP | 486 2.990% | 0 (Unchanged) | Filing History |
| 2022-02-04 4:10 pm Purchase | 2021-12-31 | 13G | PLUS THERAPEUTICS INC PSTV | Hudson Bay Capital Management LP | 36,667 3.460% | 1,302 (+3.68%) | Filing History |
| 2022-02-04 4:08 pm Sale | 2021-12-31 | 13G | LM FDG AMER INC PAR $0.001 LMFA | Hudson Bay Capital Management LP | 30,000 1.390% | -165,833 (-84.68%) | Filing History |
| 2022-02-04 4:06 pm Sale | 2021-12-31 | 13G | HELBIZ INC HLBZ | Hudson Bay Capital Management LP | 0 0.000% | -8,000 (Position Closed) | Filing History |
| 2022-02-04 4:03 pm Unchanged | 2021-12-31 | 13G | CYCLACEL PHARMACEUTICALS INC CYCC | Hudson Bay Capital Management LP | 115 3.970% | 0 (Unchanged) | Filing History |
| 2022-02-04 3:59 pm Unchanged | 2021-12-31 | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | Hudson Bay Capital Management LP | 121,921 4.080% | 0 (Unchanged) | Filing History |
| 2022-02-04 3:56 pm Unchanged | 2021-12-31 | 13G | ARCADIA BIOSCIENCES INC NE RKDA | Hudson Bay Capital Management LP | 22,251 3.860% | 0 (Unchanged) | Filing History |
| 2022-02-04 3:42 pm Sale | 2021-12-31 | 13G | YIELD10 BIOSCIENCE, INC YTEN | Hudson Bay Capital Management LP | 417 0.200% | -9,479 (-95.79%) | Filing History |
| 2022-02-04 3:39 pm Purchase | 2021-12-31 | 13G | TIMBER PHARMACEUTICALS, INC. TMBR | Hudson Bay Capital Management LP | 51,497 3.880% | 24,788 (+92.81%) | Filing History |
| 2022-02-04 3:37 pm Sale | 2021-12-31 | 13G | WISA TECHNOLOGIES INC WISA | Hudson Bay Capital Management LP | 16 1.480% | -27 (-62.79%) | Filing History |
| 2022-02-04 3:35 pm Sale | 2021-12-31 | 13G | SRAX INC CLASS A SRAX | Hudson Bay Capital Management LP | 909,088 3.360% | -1,753,968 (-65.86%) | Filing History |
| 2022-02-04 3:32 pm Purchase | 2021-12-31 | 13G | RECON TECHNOLOGY, LTD. CLASS A RCON | Hudson Bay Capital Management LP | 26,389 1.720% | 1,821 (+7.41%) | Filing History |
| 2022-02-04 3:29 pm Purchase | 2021-12-31 | 13G | INMED PHARMACEUTICALS INC INM | Hudson Bay Capital Management LP | 1,120 3.810% | 231 (+25.98%) | Filing History |
| 2022-02-04 3:26 pm Sale | 2021-12-31 | 13G | CITIC CAP ACQUISITION CORP CL CCAC | Hudson Bay Capital Management LP | 266,667 0.970% | -1,764,888 (-86.87%) | Filing History |
| 2022-02-04 3:23 pm Purchase | 2021-12-31 | 13G | CASTOR MARITIME INC SHS CTRM | Hudson Bay Capital Management LP | 340,000 3.400% | 194,370 (+133.47%) | Filing History |
| 2022-02-04 3:21 pm Purchase | 2021-12-31 | 13G | BREEZE HLDGS ACQUISITION CORP BRZH | Hudson Bay Capital Management LP | 861,240 5.880% | 61,240 (+7.66%) | Filing History |
| 2022-02-04 3:19 pm Sale | 2021-12-31 | 13G | ARTELO BIOSCIENCES INC CO ARTL | Hudson Bay Capital Management LP | 0 0.000% | -3,407 (Position Closed) | Filing History |
| 2022-02-04 3:17 pm Sale | 2021-12-31 | 13G | REVELATION BIOSCIENCES INC REVB | Hudson Bay Capital Management LP | 0 0.000% | -3 (Position Closed) | Filing History |
| 2022-02-04 3:13 pm Purchase | 2021-12-31 | 13G | NOVABAY PHARMACEUTICALS INC CO NBY | Hudson Bay Capital Management LP | 812 9.990% | 812 (New Position) | Filing History |